Angiotensin II type 2 receptor gene is not responsible for familial vesicoureteral reflux

被引:22
|
作者
Yoneda, A [1 ]
Cascio, S
Green, A
Barton, D
Puri, P
机构
[1] Univ Coll Dublin, Childrens Res Ctr, Dublin 2, Ireland
[2] Univ Coll Dublin, Natl Ctr Med Genet, Dublin 2, Ireland
[3] Our Ladys Hosp Sick Children, Dublin 12, Ireland
来源
JOURNAL OF UROLOGY | 2002年 / 168卷 / 03期
关键词
vesico-ureteral reflux; genes; angiotensins;
D O I
10.1016/S0022-5347(05)64611-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The renin-angiotensin system has an important role in the development of the kidney and ureter. It has been reported that disruption of the angiotensin II type 2 receptor (AT2) gene leads to congenital anomalies of the kidney and ureter in mice, including vesicoureteral reflux. In humans a single base A to G transition at position -1332 in intron 1 (A-1332G) of the AT2 gene has been reported to occur significantly more often in patients with ureteropelvic junction obstruction and primary obstructive megaureter than in controls. We investigate the incidence of A-1332G transition in patients with primary familial vesicoureteral reflux to determine if AT2 gene is involved in pathogenesis of this disease. Materials and Methods: We evaluated the incidence of A-1332G transition in 82 male and 110 female patients, 111 male and 124 female nonaffected family members from 88 families in which 2 or more members had primary vesicoureteral reflux, and 106 male and 107 female controls with no unselected for reflux status. Genomic DNA was extracted from whole blood samples. Polymerase chain reaction method modified for fluorescent detection was used to type all samples for the A-1332G variant. Furthermore, to identify mutations in the coding sequence of the AT2 gene, we selected 61 patients from different families as well as 15 controls with no vesicoureteral reflux status. Results: The incidence of A-1332G transition in male patients with primary familial vesicoureteral reflux and controls was 33% (27 of 82 patients) and 38% (41 of 106 controls), respectively, and, the incidence of A-1332G substituted allele in female patients and controls was 47% (104 of 220 total alleles) and 50% (107 of 214 total alleles), respectively. Moreover, the transmission/disequilibrium test revealed no significant skewing of genotype transmission from mother to children. None of the 61 patients or 15 controls carried by mutations or polymorphisms in the coding sequence of the AT2 gene. Conclusions: Although the AT2 gene has been reported to have a role in developmental anomalies of the kidney and ureter, our data indicate that it is not involved in the pathogenesis of primary familial vesicoureteral reflux.
引用
收藏
页码:1138 / 1141
页数:4
相关论文
共 50 条
  • [21] The angiotensin II type 2 receptor in the brain
    Horiuchi, Masatsugu
    Mogi, Masaki
    Iwai, Masaru
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2010, 11 (01) : 1 - 6
  • [22] Is the angiotensin II type 2 receptor cerebroprotective?
    Fournier, A
    Achard, JM
    Boutitie, F
    Mazouz, H
    Mansour, J
    Oprisiu, R
    Fernandez, L
    Messerli, F
    CURRENT HYPERTENSION REPORTS, 2004, 6 (03) : 182 - 189
  • [23] The angiotensin II type 2 receptor and the kidney
    Siragy, Helmy M.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2010, 11 (01) : 33 - 36
  • [24] Is the angiotensin ii type 2 receptor cerebroprotective?
    Albert Fournier
    Jean Michel Achard
    Florent Boutitie
    Hakim Mazouz
    Janette Mansour
    Roxana Oprisiu
    Leonardo Fernandez
    Franz Messerli
    Current Hypertension Reports, 2004, 6 : 182 - 189
  • [25] Familial vesicoureteral reflux with PAX2/EYA1 gene mutation in a Turkish family
    Mir, S.
    Berdeli, A.
    Mutlubas, F.
    ACTA PAEDIATRICA, 2008, 97 : 257 - 258
  • [26] Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II
    Miller, JA
    Thai, K
    Scholey, JW
    KIDNEY INTERNATIONAL, 1999, 56 (06) : 2173 - 2180
  • [27] Angiotensin II Type 2 Receptor Antagonizes Angiotensin II Type 1 Receptor-Mediated Cardiomyocyte Autophagy
    Porrello, Enzo R.
    D'Amore, Angelo
    Curl, Claire L.
    Allen, Andrew M.
    Harrap, Stephen B.
    Thomas, Walter G.
    Delbridge, Lea M. D.
    HYPERTENSION, 2009, 53 (06) : 1032 - 1040
  • [28] CLONING AND GENE-EXPRESSION OF TYPE-2 ANGIOTENSIN-II (AT(2) RECEPTOR
    MUKOYAMA, M
    TANAKA, I
    GOTO, M
    SUGA, S
    NAKAGAWA, M
    SUGAWARA, A
    YOSHIMASA, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 726 - 726
  • [29] TARGETED DISRUPTION OF ANGIOTENSIN-II TYPE-2 RECEPTOR (AT2) GENE
    ICHIKI, T
    HOGAN, BLM
    ICHIKAWA, I
    INAGAMI, T
    HYPERTENSION, 1995, 26 (03) : 546 - 546
  • [30] Angiotensin II type 2 receptor gene polymorphisms and cardioprotective role in essential hypertension
    Min Zhang
    Hong Ma
    Bo-song Wang
    Yong-zhong Zhao
    Heart and Vessels, 2006, 21 : 95 - 101